← Back to Search

Mobile App for Colorectal Surgery Recovery

N/A
Recruiting
Led By Erin Kennedy
Research Sponsored by Mount Sinai Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any patient who is being discharged to home after undergoing elective colorectal surgery
Able to speak and understand English or French
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial is evaluating an integrated discharge monitoring system with a mobile app to support colorectal surgery patients at home following discharge from hospital. The aim is to see if this leads to a reduction in unplanned hospital visits and improved quality of patient recovery.

Who is the study for?
This trial is for adults who've had elective colorectal surgery and are going home afterwards. They must be over 18, able to speak English or French, and give informed consent. It's not for those with short post-op hospital stays under 3 days or needing rehab before going home.Check my eligibility
What is being tested?
The study tests a mobile app designed to monitor patients at home after colorectal surgery against standard follow-up care. Participants will either use the app as part of an integrated discharge system or receive usual care, aiming to reduce unplanned hospital visits.See study design
What are the potential side effects?
Since this trial involves using a mobile app rather than medication, traditional side effects aren't expected. However, there may be issues related to usability or stress from technology use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am going home after elective surgery on my colon or rectum.
Select...
I can speak and understand English or French.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
30-day unplanned hospital visit rate
Secondary outcome measures
patient quality of recovery
patient self-efficacy to manage one's own health care

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
The intervention group will receive the same usual care as the control group plus be enrolled in the integrated discharge monitoring system.
Group II: Control GroupActive Control1 Intervention
The control group will receive usual follow up care that is currently provided at the 3 participating centres.

Find a Location

Who is running the clinical trial?

Mount Sinai Hospital, CanadaLead Sponsor
196 Previous Clinical Trials
66,938 Total Patients Enrolled
Erin KennedyPrincipal InvestigatorMOUNT SINAI HOSPITAL
1 Previous Clinical Trials
90 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being included in this research project?

"Affirmative. According to the information on clinicaltrials.gov, this research is currently enlisting participants after being initially posted on May 25th 2021 and most recently edited June 10th 2021. The study requires 670 patients from 1 site location for completion."

Answered by AI

Are there vacancies available for prospective participants of this trial?

"Confirmed. The information available on clinicaltrials.gov states that this research is actively seeking participants, with an initial posting date of May 25th 2021 and most recent update occurring June 10th 2021. A total of 670 patients need to be recruited from one site."

Answered by AI
~171 spots leftby Apr 2025